INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 106 filers reported holding INTERSECT ENT INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,769,000 | +14.1% | 55,018 | 0.0% | 0.22% | +10.0% |
Q4 2018 | $1,550,000 | -2.0% | 55,018 | 0.0% | 0.20% | +22.6% |
Q3 2018 | $1,582,000 | -23.2% | 55,018 | 0.0% | 0.16% | -33.9% |
Q2 2018 | $2,060,000 | -4.7% | 55,018 | 0.0% | 0.25% | -8.1% |
Q1 2018 | $2,162,000 | +21.3% | 55,018 | 0.0% | 0.27% | +53.4% |
Q4 2017 | $1,783,000 | +4.0% | 55,018 | 0.0% | 0.18% | +15.0% |
Q3 2017 | $1,714,000 | +11.4% | 55,018 | 0.0% | 0.15% | +9.3% |
Q2 2017 | $1,538,000 | +62.9% | 55,018 | 0.0% | 0.14% | +64.7% |
Q1 2017 | $944,000 | +41.7% | 55,018 | 0.0% | 0.08% | +44.1% |
Q4 2016 | $666,000 | -23.5% | 55,018 | 0.0% | 0.06% | -28.0% |
Q3 2016 | $871,000 | +22.5% | 55,018 | 0.0% | 0.08% | +18.8% |
Q2 2016 | $711,000 | -32.0% | 55,018 | 0.0% | 0.07% | -30.3% |
Q1 2016 | $1,045,000 | -15.6% | 55,018 | 0.0% | 0.10% | -12.4% |
Q4 2015 | $1,238,000 | -3.8% | 55,018 | 0.0% | 0.11% | -8.1% |
Q3 2015 | $1,287,000 | -18.3% | 55,018 | 0.0% | 0.12% | -9.6% |
Q2 2015 | $1,575,000 | +10.8% | 55,018 | 0.0% | 0.14% | +16.2% |
Q1 2015 | $1,421,000 | – | 55,018 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |